HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kosei Doshita Selected Research

Tyrosine Kinase Inhibitors

4/2024Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kosei Doshita Research Topics

Disease

4Neoplasms (Cancer)
05/2024 - 01/2022
4Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2024 - 01/2022
3Cachexia
05/2024 - 01/2022
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2023 - 01/2022
1Body Weight (Weight, Body)
05/2024
1Weight Gain
05/2024
1Type 2 Diabetes Mellitus (MODY)
05/2024
1Colorectal Neoplasms (Colorectal Cancer)
05/2024
1Lung Neoplasms (Lung Cancer)
04/2024
1Pneumonia (Pneumonitis)
04/2024
1Carcinoma (Carcinomatosis)
01/2024
1Febrile Neutropenia
12/2023
1Radiation Pneumonitis
03/2023
1Inflammation (Inflammations)
01/2022

Drug/Important Bio-Agent (IBA)

3Immune Checkpoint InhibitorsIBA
01/2024 - 01/2022
1anamorelinIBA
05/2024
1Ghrelin ReceptorsIBA
05/2024
1Glucose (Dextrose)FDA LinkGeneric
05/2024
1Hemoglobins (Hemoglobin)IBA
05/2024
1ErbB Receptors (EGF Receptor)IBA
04/2024
1osimertinibIBA
04/2024
1Tyrosine Kinase InhibitorsIBA
04/2024
1amrubicinIBA
12/2023
1pegfilgrastim (Neulasta)FDA Link
12/2023
1LigandsIBA
01/2023
1pembrolizumabIBA
01/2022
1Therapeutic UsesIBA
01/2022
1B7-H1 AntigenIBA
01/2022

Therapy/Procedure

6Drug Therapy (Chemotherapy)
01/2024 - 01/2022
4Therapeutics
04/2024 - 01/2022
2Immunotherapy
01/2022 - 01/2022
1Radiotherapy
03/2023
1Chemoradiotherapy
01/2022